Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1991 Apr;44(4):269–275. doi: 10.1136/jcp.44.4.269

ACP Broadsheet No 127: April 1991. Measurement of catecholamines and their metabolites in urine.

C Weinkove 1
PMCID: PMC496897  PMID: 2030143

Full text

PDF
269

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANTON A. H., SAYRE D. F. A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines. J Pharmacol Exp Ther. 1962 Dec;138:360–375. [PubMed] [Google Scholar]
  2. Beard C. M., Sheps S. G., Kurland L. T., Carney J. A., Lie J. T. Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc. 1983 Dec;58(12):802–804. [PubMed] [Google Scholar]
  3. Davidson D. F. Simultaneous assay for urinary 4-hydroxy-3-methoxy-mandelic acid, 5-hydroxyindoleacetic acid and homovanillic acid by isocratic HPLC with electrochemical detection. Ann Clin Biochem. 1989 Mar;26(Pt 2):137–143. doi: 10.1177/000456328902600208. [DOI] [PubMed] [Google Scholar]
  4. Davidson D. F. Urinary catecholamine assay by HPLC: in vitro interference by some drugs. Ann Clin Biochem. 1988 Sep;25(Pt 5):583–584. doi: 10.1177/000456328802500517. [DOI] [PubMed] [Google Scholar]
  5. Green B., Cooper J. D., Turnell D. C. An automated method for the analysis of urinary free catecholamines using ASTED and high-pressure liquid chromatography. Ann Clin Biochem. 1989 Jul;26(Pt 4):361–367. doi: 10.1177/000456328902600412. [DOI] [PubMed] [Google Scholar]
  6. Hugh D., Grennan A., Abugila M. A., Weinkove C. Ascorbic acid as an antioxidant in measurements of catecholamines in plasma. Clin Chem. 1987 Apr;33(4):569–571. [PubMed] [Google Scholar]
  7. Macdougall I. C., Isles C. G., Stewart H., Inglis G. C., Finlayson J., Thomson I., Lees K. R., McMillan N. C., Morley P., Ball S. G. Overnight clonidine suppression test in the diagnosis and exclusion of pheochromocytoma. Am J Med. 1988 Jun;84(6):993–1000. doi: 10.1016/0002-9343(88)90303-8. [DOI] [PubMed] [Google Scholar]
  8. Sisson J. C., Frager M. S., Valk T. W., Gross M. D., Swanson D. P., Wieland D. M., Tobes M. C., Beierwaltes W. H., Thompson N. W. Scintigraphic localization of pheochromocytoma. N Engl J Med. 1981 Jul 2;305(1):12–17. doi: 10.1056/NEJM198107023050103. [DOI] [PubMed] [Google Scholar]
  9. Stenström G., Svärdsudd K. Pheochromocytoma in Sweden 1958-1981. An analysis of the National Cancer Registry Data. Acta Med Scand. 1986;220(3):225–232. [PubMed] [Google Scholar]
  10. Tycko D. H., Ornstein L., Groner W. Some effects on light scattering intensity and red blood cell size histograms due to sphering. Ann Clin Biochem. 1989 Sep;26(Pt 5):457–458. doi: 10.1177/000456328902600522. [DOI] [PubMed] [Google Scholar]
  11. Worthington D. J., Hammond E. M., Eldeeb B. B., Green A., Addison G. M., Jones P. H., Mann J. R. Neuroblastoma--when are urinary catecholamines and their metabolites 'normal'? Ann Clin Biochem. 1988 Nov;25(Pt 6):620–626. doi: 10.1177/000456328802500604. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES